While discount cards may also help alleviate the stress of substantial drug prices in the short term, they do not handle the systemic problems driving up prescription costs while in the U.S. Broader policy variations could deal with the basis causes of increasing drug selling prices, like deficiency of transparency in pricing along with the role of